Trasplante renal pediátrico

Magee, 2008, Pediatric transplantation in the United States, 1997-2006, Am J Transplant, 8, 935, 10.1111/j.1600-6143.2008.02172.x Gillen, 2008, Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation, Am J Transplant, 8, 2600, 10.1111/j.1600-6143.2008.02410.x Cransberg, 2006, Kidney transplantation without prior dialysis in children: the Eurotransplant experience, Am J Transplant, 6, 1858, 10.1111/j.1600-6143.2006.01405.x Milton, 2008, Pre-emptive renal transplantation from living donors in Australia: effect on allograft and patient survival, Nephrology, 13, 535, 10.1111/j.1440-1797.2008.01011.x Matas, 2003, Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers, Am J Transplant, 3, 830, 10.1046/j.1038-5282.2001.00400.x-i1 Feld, 1997, Renal transplantation in children from 1987-1996: the 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study, Pediatr Transplant, 1, 146 Benfield, 2005, A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation, Pediatr Transplant, 9, 282, 10.1111/j.1399-3046.2005.00296.x Grenda, 2006, A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation, Am J Transplant, 6, 1666, 10.1111/j.1600-6143.2006.01367.x Offner, 2008, Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids, Transplantation, 86, 1241, 10.1097/TP.0b013e318188af15 Chavers, 2009, Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results, Transplantation, 88, 237, 10.1097/TP.0b013e3181ac6833 Li, 2010, Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation, Transplantation, 90, 1516, 10.1097/TP.0b013e3181fc8937 Bartosh, 2005, Campath-1H use in pediatric renal transplantation, Am J Transplant, 5, 1569, 10.1111/j.1600-6143.2005.00879.x Ona, 2008, Use of alemtuzumab (Campath-1H) as induction therapy in pediatric kidney transplantation, Transplant Proc, 40, 2226, 10.1016/j.transproceed.2008.07.050 Shapiro, 2008, Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody, Transplantation, 85, 1125, 10.1097/TP.0b013e31816a8a6d Webb, 2009, Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data, Pediatr Nephrol, 24, 177, 10.1007/s00467-008-0931-x Beato, 1989, Gene regulation by steroid hormones, Cell, 56, 335, 10.1016/0092-8674(89)90237-7 Paliogianni, 1993, Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT, J Clin Invest, 91, 1481, 10.1172/JCI116353 Broyer, 1992, Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation, J Pediatr, 120, 721, 10.1016/S0022-3476(05)80234-3 Jabs, 1996, Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study, Transplantation, 61, 31, 10.1097/00007890-199601150-00008 Sarwal, 2003, Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation, Transplantation, 76, 1331, 10.1097/01.TP.0000092950.54184.67 Grenda, 2010, A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study, Am J Transplant, 10, 828, 10.1111/j.1600-6143.2010.03047.x Hocker, 2009, Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil, Transplantation, 87, 934, 10.1097/TP.0b013e31819b6d4a Reisman, 1990, Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone, Transplantation, 49, 76, 10.1097/00007890-199001000-00017 1995, Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection, Lancet, 345, 1321, 10.1016/S0140-6736(95)92534-1 1996, A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation, Transplantation, 61, 1029, 10.1097/00007890-199604150-00008 Sollinger, 1995, Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients, Transplantation, 60, 225, 10.1097/00007890-199508000-00003 Ferraris, 2000, Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection, Transplantation, 70, 297, 10.1097/00007890-200007270-00010 1996, Rescue therapy with mycophenolate mofetil, Clin Transplant, 10, 131 Le Meur, 2007, Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation, Am J Transplant, 7, 2496, 10.1111/j.1600-6143.2007.01983.x Gaston, 2009, Fixed- or controlled-dose mycophenolate mofetil with standard-or reduced-dose calcineurin inhibitors: the Opticept trial, Am J Transplant, 9, 1607, 10.1111/j.1600-6143.2009.02668.x Butani, 1999, Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection, Transplantation, 68, 83, 10.1097/00007890-199907150-00016 Bunchman, 2001, The use of mycophenolate mofetil suspension in pediatric renal allograft recipients, Pediatr Nephrol, 16, 978, 10.1007/s004670100006 Kehrl, 1986, Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth, J Exp Med, 163, 1037, 10.1084/jem.163.5.1037 Schreiber, 1992, The mechanism of action of cyclosporin A and FK506, Immunol Today, 13, 136, 10.1016/0167-5699(92)90111-J Kovarik, 1994, Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients, Transplantation, 58, 658, 10.1097/00007890-199409000-00004 Mueller, 1994, Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients - a concentration-controlled comparison with the commercial formulation, Transplantation, 57, 1178, 10.1097/00007890-199404270-00007 Hoyer, 1991, Practical aspects in the use of cyclosporin in paediatric nephrology, Pediatr Nephrol, 5, 630, 10.1007/BF00856658 Kopp, 1990, Cellular and molecular mechanisms of cyclosporin nephrotoxicity, J Am Soc Nephrol, 1, 162, 10.1681/ASN.V12162 Myers, 1991, Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury, J Am Soc Nephrol, 2, S45, 10.1681/ASN.V22s45 Klintmalm, 1994, FK 506: an update, Clin Transplant, 8, 207 Trompeter, 2002, Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation, Pediatr Nephrol, 17, 141, 10.1007/s00467-001-0795-9 Filler, 2005, Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion, Pediatr Transplant, 9, 498, 10.1111/j.1399-3046.2005.00334.x Porayko, 1994, Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation, Mayo Clin Proc, 69, 105, 10.1016/S0025-6196(12)61034-9 Al-Uzri, 2001, Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Transplantation, 72, 1020, 10.1097/00007890-200109270-00007 Weintraub, 2008, Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation, Pediatr Transplant, 12, 541, 10.1111/j.1399-3046.2007.00847.x Harmon, 2006, Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation, J Am Soc Nephrol, 17, 1735, 10.1681/ASN.2006010049 Murgia, 1996, The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients, Kidney Int, 49, 209, 10.1038/ki.1996.28 Kasiske, 2008, Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients, Am J Transplant, 8, 1384, 10.1111/j.1600-6143.2008.02272.x Butani, 2004, Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue, Transplantation, 78, 1362, 10.1097/01.TP.0000140868.88149.63 Izzedine, 2005, Post-transplantation proteinuria and sirolimus, N Engl J Med, 353, 2088, 10.1056/NEJM200511103531922 Mahe, 2005, Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy, Transplantation, 79, 476, 10.1097/01.TP.0000151630.25127.3A Zuber, 2008, Sirolimus may reduce fertility in male renal transplant recipients, Am J Transplant, 8, 1471, 10.1111/j.1600-6143.2008.02267.x Ettenger, 2008, Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year, Pediatr Transplant, 12, 456, 10.1111/j.1399-3046.2007.00832.x Rocha, 2003, Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection, Transplantation, 75, 1490, 10.1097/01.TP.0000060252.57111.AC Shah, 2004, Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin, Transplantation, 77, 1399, 10.1097/01.TP.0000122187.76518.BC White, 2004, Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection, Transplantation, 78, 772, 10.1097/01.TP.0000128194.55934.48 Becker, 2004, Rituximab as treatment for refractory kidney transplant rejection, Am J Transplant, 4, 996, 10.1111/j.1600-6143.2004.00454.x Faguer, 2007, Rituximab therapy for acute humoral rejection after kidney transplantation, Transplantation, 83, 1277, 10.1097/01.tp.0000261113.30757.d1 Lefaucheur, 2009, Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection, Am J Transplant, 9, 1099, 10.1111/j.1600-6143.2009.02591.x Smith, 2007, Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), Pediatr Transplant, 11, 366, 10.1111/j.1399-3046.2007.00704.x Al-Uzri, 1998, Living-unrelated renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplant, 2, 139 Lindholm, 1993, The impact of acute rejection episodes on long-term graft function and outcome in 1 347 primary renal transplants treated by 3 cyclosporine regimens, Transplantation, 56, 307, 10.1097/00007890-199308000-00010 Dobbels, 2010, Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review, Pediatr Transplant, 14, 603, 10.1111/j.1399-3046.2010.01299.x Feinstein, 2005, Is noncompliance among adolescent renal transplant recipients inevitable?, Pediatrics, 115, 969, 10.1542/peds.2004-0211 McDonald, 2004, Long-term survival of children with end-stage renal disease, N Engl J Med, 350, 2654, 10.1056/NEJMoa031643 Tejani, 1999, Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplant, 3, 293, 10.1034/j.1399-3046.1999.00057.x Harmon, 1991, Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study, Transplantation, 51, 406, 10.1097/00007890-199102000-00026 Broyer, 1991, Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin, Transplant Proc, 23, 1384 Broyer, 1987, Hypertension following renal transplantation in children, Pediatr Nephrol, 1, 16, 10.1007/BF00866879 Broyer, 1997, Varicella and zoster in children after kidney transplantation: long-term results of vaccination, Pediatrics, 99, 35, 10.1542/peds.99.1.35 Dharnidharka, 2001, Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Transplantation, 71, 1065, 10.1097/00007890-200104270-00010 McDonald, 2008, Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids, Am J Transplant, 8, 984, 10.1111/j.1600-6143.2008.02167.x Ginevri, 2003, Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches, Transplantation, 75, 1266, 10.1097/01.TP.0000061767.32870.72 Haysom, 2004, BK viral infection in an Australian pediatric renal transplant population, Pediatr Transplant, 8, 480, 10.1111/j.1399-3046.2004.00154.x Smith, 2007, BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry, Clin J Am Soc Nephrol, 2, 1037, 10.2215/CJN.04051206 Cochat, 2009, Disease recurrence in paediatric renal transplantation, Pediatr Nephrol, 24, 2097, 10.1007/s00467-009-1137-6 Weber, 2005, Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects, Transplantation, 80, S128, 10.1097/01.tp.0000187110.25512.82 Canaud, 2009, Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study, Am J Transplant, 9, 1081, 10.1111/j.1600-6143.2009.02580.x Salomon, 2003, Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children, Transplantation, 75, 810, 10.1097/01.TP.0000055215.20367.21 Loirat, 2003, The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children, Pediatr Nephrol, 18, 1095, 10.1007/s00467-003-1289-8 Bresin, 2006, Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background, Clin J Am Soc Nephrol, 1, 88, 10.2215/CJN.00050505 Zuber, 2011, New insights into postrenal transplant hemolytic uremic syndrome, Nat Rev Nephrol, 7, 23, 10.1038/nrneph.2010.155 Le Quintrec, 2008, Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation, Am J Transplant, 8, 1694, 10.1111/j.1600-6143.2008.02297.x Sellier-Leclerc, 2007, Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome, J Am Soc Nephrol, 18, 2392, 10.1681/ASN.2006080811 Noris, 2009, Atypical hemolytic-uremic syndrome, N Engl J Med, 361, 1676, 10.1056/NEJMra0902814 Gagnadoux, 2001, Long-term results of liver-kidney transplantation in children with primary hyperoxaluria, Pediatr Nephrol, 16, 946, 10.1007/s004670100001 Penn, 1998, De novo malignances in pediatric organ transplant recipients, Pediatr Transplant, 2, 56 Smith, 2002, Renal transplant outcomes in adolescents: a report of the North American Pediatric Renal Transplant Cooperative Study, Pediatr Transplant, 6, 493, 10.1034/j.1399-3046.2002.02042.x Fine, 2009, Nonadherence consensus conference summary report, Am J Transplant, 9, 35, 10.1111/j.1600-6143.2008.02495.x Hocker, 2010, Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation, Nephrol Dial Transplant, 25, 617, 10.1093/ndt/gfp506 Pedersen, 2007, Avoiding steroids in pediatric renal transplantation: long-term experience from a single centre, Pediatr Transplant, 11, 730, 10.1111/j.1399-3046.2007.00731.x Sutherland, 2009, Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy, Transplantation, 87, 1744, 10.1097/TP.0b013e3181a5df60 Broyer, 2004, Long-term social outcome of children after kidney transplantation, Transplantation, 77, 1033, 10.1097/01.TP.0000120947.75697.8B Fine, 2002, Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS, Kidney Int, 62, 688, 10.1046/j.1523-1755.2002.00489.x Guest, 1998, Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology, Pediatr Nephrol, 12, 437, 10.1007/s004670050483 Maxwell, 1998, Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology, Arch Dis Child, 79, 481, 10.1136/adc.79.6.481